DecisionPoint Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.66K Buy
18
+5
+38% +$702 ﹤0.01% 349
2026
Q2
$1.64K Sell
13
-33
-72% -$4.35K ﹤0.01% 343
2026
Q1
$6.41K Sell
46
-13
-22% -$1.82K ﹤0.01% 206
2025
Q4
$7.24K Buy
59
+13
+28% +$1.58K ﹤0.01% 221
2025
Q3
$5.11K Hold
46
– – ﹤0.01% 171
2025
Q2
$5.14K Buy
+46
New +$4.9K ﹤0.01% 176

Other funds holding GILD

DecisionPoint Financial's GILD Position: Q3 2026 in Review

DecisionPoint Financial increased its Gilead Sciences (GILD) stake by 38% in Q3 2026, buying an estimated $702 and bringing the position to 18 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #349.

DecisionPoint Financial first reported a position in GILD in Q2 2025 and has held it in 6 quarters since. The position peaked at $7.24K in Q4 2025. 2,349 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • DecisionPoint Financial held 18 shares of Gilead Sciences worth $2.66K as of Q3 2026.
  • DecisionPoint Financial bought 5 Gilead Sciences shares in Q3 2026, an estimated $702.
  • Gilead Sciences made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #349 holding.
  • DecisionPoint Financial first reported a position in Gilead Sciences in Q2 2025 and has held it in 6 quarters since.
  • DecisionPoint Financial's Gilead Sciences position peaked at $7.24K in Q4 2025.
  • 2,349 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.